Guidelines for the Treatment of Community-acquired Pneumonia
about
Community acquired bacterial pneumoniaSevere community-acquired pneumonia: timely management measures in the first 24 hoursCommunity-acquired pneumonia in elderly patients.Surviving the first hours in sepsis: getting the basics right (an intensivist's perspective).Compliance with guidelines-recommended processes in pneumonia: impact of health status and initial signs.Retrospective epidemiological study for the characterization of community- acquired pneumonia and pneumococcal pneumonia in adults in a well-defined area of Badalona (Barcelona, Spain).Impact of weekend admission on in-hospital mortality in severe community-acquired pneumonia patients in Japan.The predisposition, infection, response and organ failure (Piro) sepsis classification system: results of hospital mortality using a novel concept and methodological approachCost effectiveness of adherence to IDSA/ATS guidelines in elderly patients hospitalized for Community-Aquired PneumoniaUpdate in critical care 2005.Patient and physician predictors of patient receipt of therapies recommended by a computerized decision support system when initially prescribed broad-spectrum antibiotics: a cohort study.Severe community-acquired pneumonia in adults: current antimicrobial chemotherapy.Overview of antimicrobial therapy in intensive care units.Guideline-concordant antimicrobial therapy for healthcare-associated pneumonia: a systematic review and meta-analysis.Social and professional influences on antimicrobial prescribing for doctors-in-training: a realist review.Precision medicine for the treatment of severe pneumonia in intensive care.Categorical Risk Perception Drives Variability in Antibiotic Prescribing in the Emergency Department: A Mixed Methods Observational Study.Adherence to guidelines and its impact on outcomes in patients hospitalized with community-acquired pneumonia at a university hospital.Adherence to guidelines for hospitalized community-acquired pneumonia over time and its impact on health outcomes and mortality.Biomarkers in the management of pneumonia.Early versus later response to treatment in patients with community-acquired pneumonia: analysis of the REACH studyCommunity-acquired pneumonia versus healthcare-associated pneumonia. The returning pendulum.Development and validation of a clinical prediction rule for severe community-acquired pneumonia.The impact on community acquired pneumonia empirical therapy of diagnostic bronchoscopic techniques.A worldwide perspective of atypical pathogens in community-acquired pneumonia.Adherence to standard operating procedures is crucial for intensive care unit survival of elderly patients.Mortality of CAP reduced in the UK: is this enough?Procalcitonin Guidance of Antibiotic Therapy in Community-acquired Pneumonia
P2860
Q22241379-F886CED0-211D-47D7-8677-B8F4AA873849Q26738591-23695E61-A9E6-4C4D-A232-FE1702EDC62DQ34048462-6EFF78F7-D748-4F6D-B0A7-1136EF42B1A4Q34170333-6462514D-0FB3-4F88-B8FB-30E4618E16CFQ34281998-A7065B52-E438-4C79-AC0B-1532B522DF49Q34462908-CAD50FF8-749C-48E6-A36B-E767068FB4B6Q34520668-E7768992-26E2-4A99-88A0-18EF5EAF0AEFQ34562396-E35DE15C-B53E-4A54-9A3B-07CFAEB739BAQ35956847-DCA6DCB2-940E-4A63-AF19-9C0332892A8FQ36442993-380EF1AE-9EF1-46BE-A0A3-C7B434FAB384Q37112152-21D62E65-9561-4CD2-9407-75A5C6FD1960Q37557686-6E637127-36B9-4F12-AE99-30480489B371Q37822457-955F91F2-51CB-4D85-A79C-93A5426D8743Q38097737-4603436A-2A7D-41A7-BB1A-31216371882DQ38599568-CD6083A0-3C54-4737-B620-EEFCD28F3DC1Q38704065-629E22B2-A8E8-495F-AEB5-C0C7F7465313Q38716209-A5433F72-A4E5-4CD5-8FEA-5D0388F0C705Q39463698-92EFD328-BFEB-4CA7-B70B-51BA6A7A9A48Q39836338-59F6502A-855A-43C6-B417-6D547BDEC649Q40041796-562635F9-9653-428F-83AF-C62C27B83234Q41894467-A56BCE74-8687-444E-AEC9-19EE4091F669Q43974180-A06CBB94-33C5-49DD-AD6B-FB7C28113211Q44818174-62047376-F5BD-4B53-BC7B-2470C4AC13B5Q44997655-449516EF-377D-4F81-87EE-E06910F02D74Q46353484-D943A7BA-CD36-4F85-8DA4-F32616F8E0D1Q47660761-BAEF7AEC-5403-40FF-A593-A4EBC76556F3Q54517688-3FDF38B6-6EC7-461D-91A5-2BB40F2A9B1DQ55966607-22FF11E4-1D00-470B-A4EE-E1488969305B
P2860
Guidelines for the Treatment of Community-acquired Pneumonia
description
im Juni 2005 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 03 June 2005
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у вересні 2005
@uk
name
Guidelines for the Treatment of Community-acquired Pneumonia
@en
Guidelines for the Treatment of Community-acquired Pneumonia
@nl
type
label
Guidelines for the Treatment of Community-acquired Pneumonia
@en
Guidelines for the Treatment of Community-acquired Pneumonia
@nl
prefLabel
Guidelines for the Treatment of Community-acquired Pneumonia
@en
Guidelines for the Treatment of Community-acquired Pneumonia
@nl
P2093
P2860
P1476
Guidelines for the treatment o ...... ctors of adherence and outcome
@en
P2093
Antoni Torres
Carlos Alvarez
Carmen Puzo
Diego Pérez
Felipe Rodríguez de Castro
Fernando Sánchez-Gascón
Javier Aspa
José Blanquer
José Gallardo
José M Benítez-Moya
P2860
P304
P356
10.1164/RCCM.200411-1444OC
P407
P577
2005-06-03T00:00:00Z